Journal of Neurogastroenterology and Motility : eISSN 2093-0887 / pISSN 2093-0879

Table. 1.

Subject Characteristics of the Case and Control Groups at Baseline (Continuous Parameters)

Characteristics Case group Control group P-valuea
N Mean ± SD N Mean ± SD
Age (yr) 2066 53.9 ± 9.3 4132 54.0 ± 9.4 0.963
BMI (kg/m2) 2063 23.5 ± 3.3 4126 22.9 ± 3.0 < 0.001
AC (cm) 2026 84.2 ± 9.1 4050 82.5 ± 8.6 < 0.001
FBS (mg/dL) 2052 102.7 ± 18.1 4103 101.4 ± 16.9 0.006
HbA1c (%) 1648 5.7 ± 0.6 3276 5.7 ± 0.5 0.321
SBP (mmHg) 2026 112.4 ± 22.3 4052 110.9 ± 22.0 0.011
DBP (mmHg) 2026 84.3 ± 22.0 4052 83.1 ± 21.9 0.052
TG (mg/dL) 2022 126.7 ± 90.2 4039 115.5 ± 72.8 < 0.001
HDL-C (mg/dL) 2025 60.4 ± 15.9 4052 61.5 ± 15.8 0.007
LDL-C (mg/dL) 1453 122.5 ± 30.2 2909 122.9 ± 29.5 0.669
TC (mg/dL) 1764 206.5 ± 32.6 3540 206.4 ± 32.9 0.889
UA (mg/dL) 1779 5.69 ± 1.32 3555 5.57 ± 1.3 0.002
AST (IU/L) 2025 24.1 ± 11.0 4052 23.0 ± 8.7 < 0.001
ALT (IU/L) 2025 26.2 ± 18.2 4052 23.5 ± 14.7 < 0.001
γ-GTP (IU/L) 2025 46.0 ± 49.4 4052 40.2 ± 44.1 < 0.001

aP-values were calculated using Student’s t test.

N, total number of subjects in the group (except subjects whose characteristics were unknown); BMI, body mass index; AC, abdominal circumference; FBS, fasting blood sugar; HbA1c, hemoglobin A1c; SBP, systolic blood pressure; DBP, diastolic blood pressure; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TC, total cholesterol; UA, uric acid; AST, aspartate aminotransferase; ALT, alanine aminotransferase; γ-GTP, γ-glutamyl transpeptidase.

J Neurogastroenterol Motil 2022;28:86~94 https://doi.org/10.5056/jnm20237
© J Neurogastroenterol Motil